174 related articles for article (PubMed ID: 30201377)
1. The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H
Bosma R; van den Bor J; Vischer HF; Labeaga L; Leurs R
Eur J Pharmacol; 2018 Nov; 838():107-111. PubMed ID: 30201377
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2006; 7(4):219-31. PubMed ID: 16784247
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
4. Differential Regulation of Bilastine Affinity for Human Histamine H
Akimoto H; Sugihara M; Hishinuma S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562121
[TBL] [Abstract][Full Text] [Related]
5. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
Farré M; Pérez-Mañá C; Papaseit E; Menoyo E; Pérez M; Martin S; Bullich S; Rojas S; Herance JR; Trampal C; Labeaga L; Valiente R
Br J Clin Pharmacol; 2014 Nov; 78(5):970-80. PubMed ID: 24833043
[TBL] [Abstract][Full Text] [Related]
6. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
[TBL] [Abstract][Full Text] [Related]
7. Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.
Lucero ML; Gonzalo A; Ganza A; Leal N; Soengas I; Ioja E; Gedey S; Jahic M; Bednarczyk D
Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():8-17. PubMed ID: 22616811
[TBL] [Abstract][Full Text] [Related]
8. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects.
Togawa M; Yamaya H; Rodríguez M; Nagashima H
Clin Drug Investig; 2016 Dec; 36(12):1011-1021. PubMed ID: 27498100
[TBL] [Abstract][Full Text] [Related]
10. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
[TBL] [Abstract][Full Text] [Related]
11. Bilastine for the relief of allergy symptoms.
Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.
Valk PJ; Simons R; Jetten AM; Valiente R; Labeaga L
Aerosp Med Hum Perform; 2016 Jul; 87(7):622-7. PubMed ID: 27503042
[TBL] [Abstract][Full Text] [Related]
13. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Bosma R; Moritani R; Leurs R; Vischer HF
Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
[TBL] [Abstract][Full Text] [Related]
14. An overview of bilastine metabolism during preclinical investigations.
Lucero ML; Gonzalo A; Mumford R; Betanzos M; Alejandro A
Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():18-24. PubMed ID: 22616812
[TBL] [Abstract][Full Text] [Related]
15. Bilastine: a new H
Church MK; Labeaga L
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
[TBL] [Abstract][Full Text] [Related]
16. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
18. Effect of the Fexofenadine on the expression of HRH-1 and HRH-4 receptor in Peripheral Blood Mononuclear Cell isolated from children with diagnosed allergy - in vitro study Short communication.
Kordulewska N; Cieślińska A; Fiedorowicz E; Jarmołowska B; Kostyra E
J Pharm Pharm Sci; 2019; 22(1):93-97. PubMed ID: 30742585
[TBL] [Abstract][Full Text] [Related]
19. Can human allergy drug fexofenadine, an antagonist of histamine (H
Sader S; Cai J; Muller ACG; Wu C
J Mol Graph Model; 2017 Aug; 75():106-116. PubMed ID: 28544909
[TBL] [Abstract][Full Text] [Related]
20. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
